Industry Symposium:
The many faces of Janus Kinase inhibitors in rheumatology
Supported by Pfizer

11:00-12:00 Industry Symposium:
The many faces of Janus Kinase inhibitors in rheumatology
Supported by Pfizer
Chairperson Wen-Chan Tsai, Taiwan
11:00 Mechanisms of action and rational for the use of JAK inhibitors in RA and PsA
Tsutomu Takeuchi, Japan
11:20 How to best use the JAK inhibitors: Lessons learned from the clinical trials and real life use
Boulos Haraoui, Canada
11:40 Q&A/Discussion